Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Satsuma Pharmaceuticals Inc (STSA)

Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Satsuma Pharmaceuticals Inc 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 94080 USA

www.satsumarx.com P: 650-410-3200

Description:

Satsuma Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company's product consists of STS101, which are in clinical stage. Satsuma Pharmaceuticals Inc. is based in San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 36,467
Enterprise Value, $K -16,013
Shares Outstanding, K 33,152
Annual Sales, $ 0 K
Annual Net Income, $ -70,060 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,290 K
60-Month Beta 0.10
% of Insider Shareholders 31.20%
% of Institutional Shareholders 93.26%
Float, K 22,809
% Float 68.80%
Short Volume Ratio 0.13

Growth:

1-Year Return -65.30%
3-Year Return -95.92%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 05/11/23
Latest Earnings Date 05/16/23
Earnings Per Share ttm -2.01
EPS Growth vs. Prev Qtr 55.71%
EPS Growth vs. Prev Year 36.73%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 03/28/14
Dividend Payout Ratio 0.00%

STSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -115.24%
Return-on-Assets % -102.26%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.97
Book Value/Share 1.14
Interest Coverage -7,005.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar